Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Comfort Systems USA Inc (FIX) vs Cassava Sciences Inc (FLNA) Price & Performance

Comfort Systems USA IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Comfort Systems USA Inc vs Cassava Sciences Inc — how do they compare? Comfort Systems USA Inc trades at $1,667.4 (market cap $61.14B), while Cassava Sciences Inc trades at $1.06 (market cap $53.14M). The key difference: Comfort Systems USA Inc is far larger — about 1150.5× Cassava Sciences Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FIXFLNA
Market Cap
$61.14B$53.14M
Sector
TechnologyHealth
52-Week High
$2.07K$4.64
52-Week Low
$532.14$1.09
Enterprise Value
$60.42B-$33.43M
Dividend Yield
0.15%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Comfort Systems USA Inc

Comfort Systems USA (FIX) trades at $1,655.80, down 6.72% over the past day, amid a bearish technical signal. The stock shows strong fundamentals with Q1 2026 EPS beating estimates at $10.51 versus $6.81 expected, and revenue growth projected from $9.10B in 2025 to $10.10B in 2026. Analyst consensus remains bullish with a $2,100 price target, supported by robust cash flow and a 53.29% ROE.

Outlook is positive due to AI infrastructure demand and record backlog, though high valuation multiples (P/E 50.14) and execution risks from rapid growth pose challenges. The stock offers growth potential but requires monitoring of margin sustainability and competitive pressures in the contracting services sector.

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Returns comparison

Trailing returns across standard periods

About Comfort Systems USA Inc

Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.

Read more on FIX

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA